Currently Viewing
MDS/AML Overlap and Novel Therapies with Dr. Naval Daver
July 24, 2018 – Aplastic Anemia and MDS International Foundation
MDS/MPN Overlap Syndromes and Myelofibrosis
July 24, 2018 – Aplastic Anemia and MDS International Foundation
Treating Children with Aplastic Anemia
July 24, 2018 – Aplastic Anemia and MDS International Foundation
Genetics and Genomics of Bone Marrow Failure
July 24, 2018 – Aplastic Anemia and MDS International Foundation
Aplastic Anemia Treatment Options
July 24, 2018 – Aplastic Anemia and MDS International Foundation
PNH Research Update
July 24, 2018 – Aplastic Anemia and MDS International Foundation
MDS and AML Biology
July 24, 2018 – Aplastic Anemia and MDS International Foundation
Non Transplant Treatments for MDS & Secondary AML
July 24, 2018 – Aplastic Anemia and MDS International Foundation
After Diagnosis: Finding Your 'New Normal'
July 23, 2018 – Kristin Reynolds

MDS/AML Overlap and Novel Therapies with Dr. Naval Daver

Dr. Naval Daver from MD Anderson Cancer Center talks about the relationship between MDS and AML and discusses new and novel treatments for both diseases.
BY Aplastic Anemia and MDS International Foundation
PUBLISHED July 24, 2018

Dr. Naval Daver from MD Anderson Cancer Center talks about the relationship between MDS and AML and discusses new and novel treatments for both diseases.

Some of the questions answered include:
How are MDS and AML connected? (define each briefly and discuss connection)
What are some new and novel therapies to treating higher risk MDS and AML?
What might these mean for patients? What do you think the future holds for treating AML secondary to MDS?

This video was recorded at the Aplastic Anemia and MDS International Foundation's Scientific Symposium in March, 2018.
Be the first to discuss this article on CURE's forum. >>
Talk about this article with other patients, caregivers, and advocates in the General Discussions CURE discussion group.

Related Articles

1
×

Sign In

Not a member? Sign up now!
×

Sign Up

Are you a member? Please Log In